Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Global Alliance for Rabies Control (GARC) is a leading international non-profit organization dedicated to eliminating human deaths from dog-mediated rabies. Founded in 2007, the organization serves as a central coordinator for global rabies prevention efforts, working closely with the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) under the 'United Against Rabies' collaboration. GARC focuses on a 'One Health' approach, integrating human and animal health strategies to control the virus at its source through mass dog vaccination. The organization provides critical technical tools, such as the Rabies Epidemiological Bulletin and the GARC Data Management System, to help endemic countries track and manage outbreaks. Additionally, GARC leads community education initiatives and manages World Rabies Day to raise global awareness and advocate for policy changes. Their work is instrumental in the 'Zero by 30' global strategic plan to end human rabies deaths by 2030.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Alliance for Rabies Control.